Wilterding Mark

Wilterding Mark is listed in filings as Chief Financial Officer at RxSight, Inc.. This profile follows SEC Form 4 activity through Mar 3, 2026, including 4 public disclosures. Recent filings connect the profile to RxSight, Inc. (RXST). The current snapshot covers public activity from Jan 30, 2026 to Mar 3, 2026. Reported amounts are shown as $61.4K to $2.6M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.